Menu

Latest news & events

Uyên Châu Nguyên wins UM Dissertation Prize 2025

Uyên Châu Nguyên wins UM Dissertation Prize 2025

29 January 2026

During the Dies Natalis of Maastricht University, Uyên Châu Nguyên received the UM Dissertation Prize 2025.

Read more
Global research network launched to study menopause and heart health

Global research network launched to study menopause and heart health

20 January 2026

Ten international health research funders, including the Dutch Heart Foundation, are investing $10 million in a new global research network to improve early prevention of cardiovascular disease in women. The initiative focuses on understanding how menopause affects heart health and how early intervention can reduce risk.

Read more
More newsMore events
Carim Maastricht
Carim Maastricht

Christian Knackstedt

Associate professor

Dr Christian Knackstedt was born in in Giessen (Germany). After completing his secondary school (Gymnasium) in Münster, he started his medical training at the University of Münster, Germany. During his studies, he spent some time abroad in France, Switzerland, and the US and finally obtained his medical degree.

After an interim position at the Department of Cardiology, Herz- und Diabeteszentrum, Bad Oeynhausen, he soon moved to the University Hospital at the RWTH Aachen University where he pursued his formation as internist and cardiologist. Also, he succeeded in obtaining his German 'promotion' and later 'habilitation' besides passing the board examinations for internal medicine, cardiology and sport medicine. Gaining some more expertise in the field of sport cardiology as a senior physician at the Institute of Cardiology and Sports medicine, German Sport University Cologne, Cologne, Germany, he finally returned to his roots as a clinical cardiologist at Maastricht UMC+. He now holds a position as senior physician with an expertise in heart failure.

My research interest has always been the niche between heart failure and imaging/ mostly echocardiography. One of the topics I am currently interested in, is early detection of cardiac dysfunction. This goes hand in hand with the application of new echocardiographic techniques in the clinical practice. Also, I have been engaged and involved in research activities to improve therapy of heart failure by different means.

Christian-knackstedt

Department of Cardiology
Universiteitssingel 50, 6229 ER Maastricht
PO Box 616, 6200 MD Maastricht

  • 2026
    • Venner, M. F. G. H. M., Verdonschot, J. A. J., & Knackstedt, C. (2026). Letter to the editor: Diastolic dysfunction as predictive parameter for the development of post-TIPS cardiac decompensation. International Journal of Cardiology, 442, Article 133886. https://doi.org/10.1016/j.ijcard.2025.133886
    • Mourmans, S. G. J., Achten, A., Weerts, J., Scheepers, M., Barandiarán Aizpurua, A., Henkens, M., Uszko-Lencer, N., Brunner-La Rocca, H.-P., Knackstedt, C., & van Empel, V. P. M. (2026). The diagnostic yield of an elaborate workup for comorbidities in a real-life heart failure with preserved ejection fraction outpatient population. European Journal of Preventive Cardiology, 33(2), 276-285. https://doi.org/10.1093/eurjpc/zwaf429
  • 2025
    • Weerts, J., Aizpurua, A. B., Patel, R. B., van de Bovenkamp, A. A., Amin, H., Sanders-van Wijk, S., Mourmans, S. G. J., Achten, A., Handoko, M. L., Bayes-Genis, A., Brunner-La Rocca, H.-P., Shah, S. J., Knackstedt, C., & van Empel, V. P. M. (2025). A simplified approach for diagnosing heart failure with preserved ejection fraction by assessing the left atrium and natriuretic peptides. European journal of heart failure, 27(12), 2897-2902. https://doi.org/10.1002/ejhf.3651
    • Li, X., Achten, A., Nassiri, S., Mourmans, S., van de Bovenkamp, A. A., Knackstedt, C., Handoko, M. L., Weerts, J., & van Empel, V. (2025). Sex-specific performance of clinical diagnostic algorithms for HFpEF across two independent cohorts. Netherlands Heart Journal, 33(12), 412-420. https://doi.org/10.1007/s12471-025-02000-y
    • Achten, A., Peeters, L., Verkoulen, G., Weerts, J., Knackstedt, C., Boerma, E.-J., van Empel, V., & Wijk, S. S. (2025). Time to screen: rationale and roadmap for HFpEF screening in individuals with obesity. Heart Failure Reviews, 30(6), 1207-1213. https://doi.org/10.1007/s10741-025-10540-z
    • Tingen, H. S. A., Berends, M., Tubben, A., van der Meer, P., Slart, R. H. J. A., Bijzet, J., van der Zwaag, P. A., Kimmich, C., Knackstedt, C., Muntinghe, F. L. H., Houwerzijl, E. J., Hazenberg, B. P. C., & Nienhuis, H. L. A. (2025). Detecting early cardiomyopathy in transthyretin variant carriers: reappraising the diagnostic value of Perugini grade 1 radiotracer uptake on bone scintigraphy. European Journal of Nuclear Medicine and Molecular Imaging, 52(13), 5000-5005. https://doi.org/10.1007/s00259-025-07328-6
    • Chua, A. P. A., Weerts, J., Achten, A., Nabeta, T., Sarrazyn, C., Lopez-Santi, P., Mourmans, S. G. J., Su, J. L., Bax, J. J., Knackstedt, C., van Empel, V. P. M., & Ajmone-Marsan, N. (2025). Left Atrial Strain Index in Patients with Heart Failure with Preserved Ejection Fraction. Journal of the American Society of Echocardiography, 38(11), 1099-1101. https://doi.org/10.1016/j.echo.2025.07.008
    • Schoonvelde, S. A. C., Nollet, E. E., Zwetsloot, P. P., Knackstedt, C., Germans, T., Hirsch, A., Schinkel, A. F. L., van Slegtenhorst, M. A., Verhagen, J. M. A., de Boer, R. A., van der Velden, J., & Michels, M. (2025). Genotype-negative hypertrophic cardiomyopathy: Exploring the role of cardiovascular risk factors in disease expression. International Journal of Cardiology, 437, Article 133444. https://doi.org/10.1016/j.ijcard.2025.133444
    • Sikking, M., Wiethoff, I., Henkens, M., Evers, S., Stroeks, S., Venner, M., Weerts, J., Brunner-la Rocca, H.-P., Knackstedt, C., van Empel, V., Michels, M., Heymans, S., Hiligsmann, M., & Verdonschot, J. (2025). High societal costs and reduced health-related quality of life in inflammatory and systemic immune disease-associated dilated cardiomyopathies. Quality of Life Research, 34(10), 2901-2910. https://doi.org/10.1007/s11136-025-04027-5
    • Schoonvelde, S. A. C., Zwetsloot, P.-P., Hirsch, A., Schinkel, A. F. L., Knackstedt, C., Germans, T., van Slegtenhorst, M. A., Verhagen, J. M. A., de Boer, R. A., & Michels, M. (2025). Accelerometry-defined physical activity and quality of life in hypertrophic cardiomyopathy. Heart, Article 326217. https://doi.org/10.1136/heartjnl-2025-326217
    • Weerts, J., Schroen, B. L. M., Barandiaran Aizpurua, A., Berendschot, T. T. J. M., Brandts, L., Webers, C. A. B., Simons, S. O., Meex, S. J. R., Henry, R., van der Kallen, C. J. H., Brunner-La Rocca, H.-P., Knackstedt, C., Heymans, S. R. B., de Boer, R. A., van Empel, V. P. M., & Houben, A. J. H. M. (2025). Microvascular dysfunction across organs in heart failure with preserved ejection fraction: the PROSE-HFpEF case-control study. Cardiovascular Diabetology, 24(1), Article 310. https://doi.org/10.1186/s12933-025-02850-1
    • Venner, M. F. G. H. M., Gevers, T. J. G., Ploum, F., Habets, J., Raafs, A. G., Weerts, J., Heymans, S. R. B., van der Leij, C., de Haan, M. W., Verdonschot, J. A. J., Kramer, M., & Knackstedt, C. (2025). Diastolic dysfunction as predictive parameter for the development of post-TIPS cardiac decompensation. International Journal of Cardiology, 431, Article 133226. https://doi.org/10.1016/j.ijcard.2025.133226
    • Weerts, J., Mourmans, S. G. J., Lopez-Martinez, H., Domingo, M., Aizpurua, A. B., Henkens, M. T. H. M., Achten, A., Lupon, J., Brunner-La Rocca, H.-P., Knackstedt, C., Bayes-Genis, A., & van Empel, V. P. M. (2025). Inter-atrial block as a predictor of adverse outcomes in patients with HFpEF. Esc heart failure, 12(3), 2287-2297. https://doi.org/10.1002/ehf2.15179
    • Achten, A., van Empel, V. P. M., Weerts, J., Mourmans, S., Brunner-La Rocca, H.-P., Sanders-van Wijk, S., & Knackstedt, C. (2025). Prevalence of transthyretin amyloid cardiomyopathy in an unselected cohort with heart failure with preserved ejection fraction. Netherlands Heart Journal, 33(6), 193-198. https://doi.org/10.1007/s12471-025-01954-3
    • Wiethoff, I., Schoonvelde, S. A. C., de Boer, R. A., Evers, S. M. A. A., Germans, T., Hirsch, A., Knackstedt, C., Te Rijdt, W. P., van Slegtenhorst, M. A., Schinkel, A. F. L., Zwetsloot, P.-P., Michels, M., & Hiligsmann, M. (2025). Assessing the psychometric properties of generic (EQ-5D-5L) and disease-specific (KCCQ) quality of life in patients with hypertrophic cardiomyopathy in the AFFECT-HCM study. Open Heart, 12(1), Article e003143. https://doi.org/10.1136/openhrt-2024-003143
    • Mourmans, S. G. J., Achten, A., Hermans, R., Scheepers, M. J. E., D'Alessandro, E., Swennen, G., Woudstra, J., Appelman, Y., Goor, H. V., Schalkwijk, C., Knackstedt, C., Weerts, J., Eringa, E. C., & van Empel, V. P. M. (2025). The effect of empagliflozin on peripheral microvascular dysfunction in patients with heart failure with preserved ejection fraction. Cardiovascular Diabetology, 24(1), Article 182. https://doi.org/10.1186/s12933-025-02679-8
    • Vranken, N. P. A., Li, X., Bouman, H., Mourmans, S. G. J., Achten, A., Aizpurua, A. B., Brunner-La Rocca, H.-P., Knackstedt, C., van Empel, V. P. M., & Weerts, J. (2025). Temporal prevalence and prognostic impact of diabetes mellitus and albuminuria in heart failure with preserved ejection fraction. Cardiovascular Diabetology, 24(1), Article 156. https://doi.org/10.1186/s12933-025-02708-6
    • Achten, A., Weerts, J., van Koll, J., Ghossein, M., Mourmans, S. G. J., Aizpurua, A. B., van Stipdonk, A. M. W., Vernooy, K., Prinzen, F. W., Rocca, H.-P. B.-L., Knackstedt, C., & van Empel, V. P. M. (2025). Prevalence and prognostic value of ventricular conduction delay in heart failure with preserved ejection fraction. IJC Heart and Vasculature, 57, Article 101622. https://doi.org/10.1016/j.ijcha.2025.101622
    • Gingele, A. J., Amin, H., De Wit, K., Jacobsen, M., Hageman, A., van der Mierden, K., Brandts, J., Weerts, J., Barrett, M., Dixon, L. J., Hill, L., Knackstedt, C., & Brunner-La Rocca, H.-P. (2025). Developing an artificial intelligence-based decision engine for disease-modifying therapy in heart failure: a pilot study. European Heart Journal - Digital Health, 6(2), 285-288. https://doi.org/10.1093/ehjdh/ztad075
    • Schoonvelde, S. A. C., Wiethoff, I., Zwetsloot, P. P., Hirsch, A., Knackstedt, C., Germans, T., Sikking, M., Schinkel, A. F. L., van Slegtenhorst, M. A., Verhagen, J. M. A., de Boer, R. A., Evers, S. M. A. A., Hiligsmann, M., & Michels, M. (2025). Loss of quality of life and increased societal costs in patients with hypertrophic cardiomyopathy: the AFFECT-HCM study. European heart journal - Quality of care & clinical outcomes, 11(2), 174-185. https://doi.org/10.1093/ehjqcco/qcae092
    • Achten, A., Muller, S. A., Zwetsloot, P.-P., Michels, M., van der Meer, P., Nienhuis, H. L. A., van der Meer, M. G., van Empel, V. P. M., Oerlemans, M. I. F. J., & Knackstedt, C. (2025). Is transthyretin amyloid cardiomyopathy heading towards losing its rare disease classification?Expert review of cardiovascular therapy, 23(1-2), 1-4. https://doi.org/10.1080/14779072.2025.2463333
    • Mourmans, S. G. J., Weerts, J., Baumert, M., Aizpurua, A. B., Achten, A., Knackstedt, C., Linz, D., & van Empel, V. P. M. (2025). Prognostic value of hypoxaemic burden from overnight oximetry in heart failure with preserved ejection fraction. Esc heart failure, 12(1), 622-630. https://doi.org/10.1002/ehf2.15116
  • 2024
    • Sikking, M. A., Harding, D., Henkens, M. T. H. M., Stroeks, S. L. V. M., Venner, M. F. G. H. M., Nihant, B., van Leeuwen, R. E. W., Fanti, S., Li, X., van Paassen, P., Knackstedt, C., Brunner-la Rocca, H.-P., van Empel, V. P. M., Verdonschot, J. A. J., Marelli-Berg, F. M., & Heymans, S. R. B. (2024). Cytotoxic T-Cells Drive Outcome in Inflammatory Dilated Cardiomyopathy. Circulation Research, 135(12), 1193-1195. https://doi.org/10.1161/CIRCRESAHA.124.325183
    • Achten, A., Muller, S. A., Wijk, S. S., van der Meer, M. G., van der Harst, P., van Tintelen, P., Te Riele, A. S., van Empel, V., Oerlemans, M. I., & Knackstedt, C. (2024). Diversity of heart failure phenotypes in transthyretin amyloid cardiomyopathy. More than just heart failure with preserved ejection fraction. Annals of Medicine, 56(1), Article 2418965. https://doi.org/10.1080/07853890.2024.2418965
    • Achten, A., van Empel, V. P. M., Weerts, J., Mourmans, S., Beckers-Wesche, F., Spanjers, M., Gingele, A., Brunner-La Rocca, H.-P., Sanders-van Wijk, S., & Knackstedt, C. (2024). Changes in the diagnostic trajectory of transthyretin cardiac amyloidosis over six years. Heart and Vessels, 39(10), 857-866. https://doi.org/10.1007/s00380-024-02408-3
    • Muller, S. A., Peiro-Aventin, B., Biagioni, G., Tini, G., Saturi, G., Kronberger, C., Achten, A., Dobner, S., te Rijdt, W. P., Gasperetti, A., te Riele, A. S. J. M., Varra, G. G., Ponziani, A., Hirsch, A., Porcari, A., van Der Meer, M. G., Zampieri, M., van Der Harst, P., Kammerlander, A., ... Oerlemans, M. I. F. J. (2024). Evaluation of the 2021 ESC recommendations for family screening in hereditary transthyretin cardiac amyloidosis. European journal of heart failure, 26(9), 2025-2034. https://doi.org/10.1002/ejhf.3339
    • Muller, S. A., Achten, A., van der Meer, M. G., Zwetsloot, P.-P., Sanders-van Wijk, S., van der Harst, P., van Tintelen, J. P., te Riele, A. S. J. M., van Empel, V., Knackstedt, C., & Oerlemans, M. I. F. J. (2024). Absence of an increased wall thickness does not rule out cardiac amyloidosis. Amyloid-journal of Protein Folding Disorders, 31(3), 244-246. https://doi.org/10.1080/13506129.2024.2348681
    • Nebhwani, M., Chaibekava, K., Achten, A., Oerlemans, M. I. F. J., Michels, M., van der Meer, P., Nienhuis, H. L. A., Weerts, J., van Empel, V., Rocca, H. P. B. L., Wijk, S. S. V., van der Pol, J., & Knackstedt, C. (2024). Detection of cardiac amyloidosis on routine bone scintigraphy: an important gatekeeper role for the nuclear medicine physician. International Journal of Cardiovascular Imaging, 40(6), 1183-1192. https://doi.org/10.1007/s10554-024-03085-z
    • Tingen, H. S. A., Tubben, A., Bijzet, J., van den Berg, M. P., van der Meer, P., Houwerzijl, E. J., Muntinghe, F. L. H., van der Zwaag, P. A., Glaudemans, A. W. J. M., Oerlemans, M. I. F. J., Knackstedt, C., Michels, M., Hirsch, A., Hazenberg, B. P. C., Slart, R. H. J. A., & Nienhuis, H. L. A. (2024). Cardiac [99mTc]Tc-hydroxydiphosphonate uptake on bone scintigraphy in patients with hereditary transthyretin amyloidosis: an early follow-up marker?European Journal of Nuclear Medicine and Molecular Imaging, 51(3), 681-690. https://doi.org/10.1007/s00259-023-06459-y
    • Boeckmans, J., Sandrin, L., Knackstedt, C., & Schattenberg, J. M. (2024). Liver stiffness as a cornerstone in heart disease risk assessment. Liver International, 44(2), 344-356. https://doi.org/10.1111/liv.15801
    • HENKENS, MICHIEL. T. H. M., RAAFS, ANNE. G., VANLOON, T. I. M., VOS, JACQUELINE. L., VANDENWIJNGAARD, ARTHUR., BRUNNER, HAN. G., KRAPELS, INGRID. P. C., KNACKSTEDT, CHRISTIAN., GERRETSEN, SUZANNE., HAZEBROEK, MARK. R., VERNOOY, KEVIN., NIJVELDT, ROBIN., LUMENS, JOOST., & VERDONSCHOT, JOB. A. J. (2024). Left Atrial Function in Patients with Titin Cardiomyopathy. Journal of Cardiac Failure, 30(1), 51-60. https://doi.org/10.1016/j.cardfail.2023.05.013
    • Gingele, A. J., Brandts, L., Vossen, K., Knackstedt, C., Boyne, J., & Rocca, H. P. B. L. (2024). Prognostic value of signs and symptoms in heart failure patients using remote telemonitoring. Journal of Telemedicine and Telecare, 30(1), 180–185. Article 1357633X211039404. https://doi.org/10.1177/1357633X211039404
  • 2023
    • Knackstedt, C., Ramaekers, B., Schummers, G., Schreckenberg, M., Faessen, J., Marx, N., Becker, M., Sanders-van Wijk, S., van Empel, V., Norra, C., Kunert, H. J., Brunner-La Rocca, H.-P., & PsychEcho study group (2023). Influence of Individual Personality Traits of the Reader on Visual Assessment of Left Ventricular Ejection Fraction: Another Reason to Abandon Visual Assessment. Journal of the American Society of Echocardiography, 36(12), 1332-1335. https://doi.org/10.1016/j.echo.2023.08.015
    • Weerts, J., Amin, H., Barandiarán Aizpurua, A., Gevaert, A. B., Handoko, M. L., Dauw, J., Tun, H. N., Rommel, K.-P., Verbrugge, F. H., Kresoja, K.-P., Sanders-van Wijk, S., Brunner-La Rocca, H.-P., Bayés-Genís, A., Lumens, J., Knackstedt, C., & van Empel, V. P. M. (2023). Webtool to enhance the accuracy of diagnostic algorithms for HFpEF: a prospective cross-over study. Esc heart failure, 10(6), 3493 - 3503. https://doi.org/10.1002/ehf2.14525
    • Kerstens, T. P., Weerts, J., van Dijk, A. P. J., Weijers, G., Knackstedt, C., Eijsvogels, T. M. H., Oxborough, D., van Empel, V. P. M., & Thijssen, D. H. J. (2023). Association of left ventricular strain-volume loop characteristics with adverse events in patients with heart failure with preserved ejection fraction. European Heart Journal Cardiovascular Imaging, 24(9), 1168-1176. https://doi.org/10.1093/ehjci/jead117
    • Raafs, A. G., Adriaans, B. P., Henkens, M. T. H. M., Verdonschot, J. A. J., Abdul Hamid, M. A., Díez, J., Knackstedt, C., van Empel, V. P. M., Brunner-La Rocca, H. P., González, A., Wildberger, J. E., Heymans, S. R. B., & Hazebroek, M. R. (2023). Biomarkers of Collagen Metabolism Are Associated with Left Ventricular Function and Prognosis in Dilated Cardiomyopathy: A Multi-Modal Study. Journal of Clinical Medicine, 12(17), Article 5695. https://doi.org/10.3390/jcm12175695
    • van Mourik, M. J. W., Linz, D., Verwijs, H. J. A., Bekkers, S. C. A. M., Weerts, J., Schotten, U., Rocca, H. B.-L., Lumens, J., Crijns, H. J. G. M., Weijs, B., & Knackstedt, C. (2023). Evaluating subclinical left ventricular and left atrial dysfunction in idiopathic atrial fibrillation: A speckle-tracking based strain-analysis. International Journal of Cardiology, 383(1), 159-165. https://doi.org/10.1016/j.ijcard.2023.04.024
    • Kerstens, T. P., Weerts, J., van Dijk, A. P. J., Weijers, G., Knackstedt, C., Eijsvogels, T. M. H., Oxborough, D., van Empel, V. P. M., & Thijssen, D. H. J. (2023). Left ventricular strain-volume loops and diastolic dysfunction in suspected heart failure with preserved ejection fraction. International Journal of Cardiology, 378(1), 144-150. https://doi.org/10.1016/j.ijcard.2023.01.084
    • Knackstedt, C., Schummers, G., Schroder, J., Marx, N., Lumens, J., Sanders-van Wijk, S., Ramaekers, B., Becker, M., van Empel, V., Brunner-La Rocca, H. P., & PsychEcho study group (2023). A graphical analysis of aspects contributing to the spreading of measurements of left ventricular function. International Journal of Cardiovascular Imaging, 39(5), 915-927. https://doi.org/10.1007/s10554-023-02796-z
    • Nuzzi, V., Raafs, A., Manca, P., Henkens, M. T. H. M., Gregorio, C., Boscutti, A., Verdonschot, J., Hazebroek, M., Knackstedt, C., Merlo, M., Stolfo, D., Sinagra, G., & Heymans, S. R. B. (2023). Left Atrial Reverse Remodeling in Dilated Cardiomyopathy. Journal of the American Society of Echocardiography, 36(2), 154-162. https://doi.org/10.1016/j.echo.2022.10.017
  • 2022
    • Gingele, A. J., Boyne, J., Knackstedt, C., & Brunner-La Rocca, H. P. (2022). The MIS-HF in clinical practice. Netherlands Heart Journal, 30(12), 582-583. https://doi.org/10.1007/s12471-022-01731-6
    • Raafs, A. G., Adriaans, B. P., Henkens, M. T. H. M., Verdonschot, J. A. J., Ramaekers, M. J. F. G., Gommers, S., Hamid, M. A. A., Schalla, S., Knackstedt, C., van Empel, V. P. M., Hans-Peter, B., Wildberger, J. E., Bekkers, S. C. A. M., & Hazebroek, M. R. (2022). Myocardial Fibrosis Assessment Using T1 and ECV Mapping With Histologic Validation in Chronic Dilated Cardiomyopathy. JACC-Cardiovascular Imaging, 15(10), 1828-1830. https://doi.org/10.1016/j.jcmg.2022.05.002
    • Gingele, A. J., Brandts, L., Brunner-La Rocca, H. P., Cleuren, G., Knackstedt, C., & Boyne, J. J. J. (2022). Introduction of a new scoring tool to identify clinically stable heart failure patients. Netherlands Heart Journal, 30(9), 402-410. https://doi.org/10.1007/s12471-021-01654-8
    • van Stipdonk, A. M. W., Schretlen, S., Dohmen, W., Knackstedt, C., Beckers-Wesche, F., Debie, L., Brunner-La Rocca, H.-P., & Vernooy, K. (2022). Better outcome at lower costs after implementing a CRT-care pathway: comprehensive evaluation of real-world data. Esc heart failure, 9(4), 2518-2527. https://doi.org/10.1002/ehf2.13958
    • Henkens, M. T. H. M., Stroeks, S. L. V. M., Raafs, A. G., Sikking, M. A., Tromp, J., Ouwerkerk, W., Hazebroek, M. R., Krapels, I. P. C., Knackstedt, C., van den Wijngaard, A., Brunner, H. G., Heymans, S. R. B., & Verdonschot, J. A. J. (2022). Dynamic Ejection Fraction Trajectory in Patients With Dilated Cardiomyopathy With a Truncating Titin Variant. Circulation-Heart Failure, 15(8), Article e009352. https://doi.org/10.1161/CIRCHEARTFAILURE.121.009352
    • Raafs, A. G., Ghossein, M. A., Brandt, Y., Henkens, M. T. H. M., Kooi, M. E., Vernooy, K., Spaanderman, M. E. A., Gerretsen, S., van Santen, S., Driessen, R. G. H., Knackstedt, C., van der Horst, I. C. C., van Bussel, B. C. T., Heymans, S. R. B., Ghossein-Doha, C., & MaastrICCht Collaborators (2022). Cardiovascular outcome 6 months after severe coronavirus disease 2019 infection. Journal of Hypertension, 40(7), 1278-1287. https://doi.org/10.1097/hjh.0000000000003110
    • Verhaert, D. V. M., Linz, D., Chaldoupi, S. M., Westra, S. W., den Uijl, D. W., Philippens, S., Kerperien, M., Habibi, Z., Vorstermans, B., ter Bekke, R. M. A., Beukema, R. J., Evertz, R., Hemels, M. E. W., Luermans, J. G. L. M., Manusama, R., Lankveld, T. A. R., van der Heijden, C. A. J., Bidar, E., Hermans, B. M., ... Schotten, U. (2022). Rationale and Design of the ISOLATION Study: A Multicenter Prospective Cohort Study Identifying Predictors for Successful Atrial Fibrillation Ablation in an Integrated Clinical Care and Research Pathway. Frontiers in Cardiovascular Medicine, 9, Article 879139. https://doi.org/10.3389/fcvm.2022.879139
    • Raafs, A. G., Vos, J. L., Henkens, M. T. H. M., Slurink, B. O., Verdonschot, J. A. J., Bossers, D., Roes, K., Gerretsen, S., Knackstedt, C., Hazebroek, M. R., Nijveldt, R., & Heymans, S. R. B. (2022). Left Atrial Strain Has Superior Prognostic Value to Ventricular Function and Delayed-Enhancement in Dilated Cardiomyopathy. JACC-Cardiovascular Imaging, 15(6), 1015-1026. https://doi.org/10.1016/j.jcmg.2022.01.016
    • Henkens, M. T. H. M., Weerts, J., Verdonschot, J. A. J., Raafs, A. G., Stroeks, S., Sikking, M. A., Amin, H., Mourmans, S. G. J., Geraeds, C. B. G., Sanders-van Wijk, S., Aizpurua, A. B., Uszko-Lencer, N. H. M. K., Krapels, I. P. C., Wolffs, P. F. G., Brunner, H. G., Leeuwen, R. E. W., Verhesen, W., Schalla, S. M., van Stipdonk, A. W. M., ... Heymans, S. R. B. (2022). Improving diagnosis and risk stratification across the ejection fraction spectrum: the Maastricht Cardiomyopathy registry. Esc heart failure, 9(2), 1463-1470. https://doi.org/10.1002/ehf2.13833
    • Raafs, A. G., Boscutti, A., Henkens, M. T. H. M., van den Broek, W. W. A., Verdonschot, J. A. J., Weerts, J., Stolfo, D., Nuzzi, V., Manca, P., Hazebroek, M. R., Knackstedt, C., Merlo, M., Heymans, S. R. B., & Sinagra, G. (2022). Global Longitudinal Strain is Incremental to Left Ventricular Ejection Fraction for the Prediction of Outcome in Optimally Treated Dilated Cardiomyopathy Patients. Journal of the American Heart Association, 11(6), Article e024505. https://doi.org/10.1161/JAHA.121.024505
Overview